Stay updated on Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedRecruitment status now shows No longer looking for participants; new navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting was standardized, and the footer revision label updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check15 days agoChange DetectedThe page footer now shows Revision: v3.5.5 instead of v3.5.4, indicating a back-end/template update with no changes to the study content or core functionality.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a maintenance/version update to the page rather than changes to study information or functionality.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page footer’s software/site revision label was updated from v3.5.2 to v3.5.3, reflecting a minor platform maintenance change rather than any alteration to the study record content.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check93 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.